There’s a new clinical trial published in the New England Journal of Medicine showing a beneficial effect due to cannabidiol, a chemical isolated from marijuana, on drug-resistant seizures due to Dravet syndrome. Medical marijuana advocates are crowing, “I told you so!” As is usually the case, the real story is more nuanced.
Search: “debate”
We found 892 results for your search.
Antivaxers are planning on publishing the personal information of employees of the Boston Herald because the paper published an editorial saying that promoting antivaccine misinformation among a vulnerable population should be a “hanging offense.” Meanwhile, overblown allusions to the Holocaust are going into overdrive. Same as it ever was.
Share this:
Ill-advised right-to-try bills are spreading like kudzu through state legislatures. Now federal legislators want to insert right-to-try language into the bill that funds FDA drug approval. Given the support of powerful Republicans for right-to-try, is it too late to stop this juggernaut and protect patients?
Share this:
In less than two weeks, the Trump administration will have passed that magical “first 100 days” marker. Let’s check in and see how Donald Trump is shaping federal biomedical policy thus far. Hint: It’s deregulation über alles.
Share this:
Cranks love ’em: Cash “challenges” demanding that skeptics and scientists “prove” the scientific consensus. Of course, these challenges are always rigged.
